Jacobsen Capital Management Takes $224,000 Position in Gilead Sciences, Inc. $GILD
MarketBeat
Jacobsen Capital Management bought a new stake in Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 2,018 shares of the biopharmaceutical company's stock, valued
NASDAQ:GILD